scholarly journals Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington’s Disease Knock-In Mouse Models

2018 ◽  
Vol 7 (2) ◽  
pp. 137-150 ◽  
Author(s):  
Nicholas R. Franich ◽  
Manuela Basso ◽  
Emily A. André ◽  
Joseph Ochaba ◽  
Amit Kumar ◽  
...  
2019 ◽  
Vol 151 (4) ◽  
pp. 507-519 ◽  
Author(s):  
Erich E. Wanker ◽  
Anne Ast ◽  
Franziska Schindler ◽  
Philipp Trepte ◽  
Sigrid Schnoegl

2019 ◽  
Vol 2 (5) ◽  
pp. e201900489 ◽  
Author(s):  
Fahmida Aktar ◽  
Chakkapong Burudpakdee ◽  
Mercedes Polanco ◽  
Sen Pei ◽  
Theresa C Swayne ◽  
...  

Inclusions of disordered protein are a characteristic feature of most neurodegenerative diseases, including Huntington’s disease. Huntington’s disease is caused by expansion of a polyglutamine tract in the huntingtin protein; mutant huntingtin protein (mHtt) is unstable and accumulates in large intracellular inclusions both in affected individuals and when expressed in eukaryotic cells. Using mHtt-GFP expressed in Saccharomyces cerevisiae, we find that mHtt-GFP inclusions are dynamic, mobile, gel-like structures that concentrate mHtt together with the disaggregase Hsp104. Although inclusions may associate with the vacuolar membrane, the association is reversible and we find that inclusions of mHtt in S. cerevisiae are not taken up by the vacuole or other organelles. Instead, a pulse-chase study using photoconverted mHtt-mEos2 revealed that mHtt is directly and continuously removed from the inclusion body. In addition to mobile inclusions, we also imaged and tracked the movements of small particles of mHtt-GFP and determine that they move randomly. These observations suggest that inclusions may grow through the collision and coalescence of small aggregative particles.


2020 ◽  
Vol 11 (2) ◽  
pp. 1334-1348 ◽  
Author(s):  
Xun Sun ◽  
Jie Zhu ◽  
Xiao-ying Sun ◽  
Mei Ji ◽  
Xiao-lin Yu ◽  
...  

Ellagic acid significantly attenuated motor and cognitive deficits and ameliorated neuropathological features in the R6/2 mouse model of Huntington's disease.


2007 ◽  
Vol 27 (7) ◽  
pp. 867-875 ◽  
Author(s):  
Mohammad Mehdi Banoei ◽  
Massoud Houshmand ◽  
Mehdi Shafa Shariat Panahi ◽  
Parvin Shariati ◽  
Maryam Rostami ◽  
...  

eLife ◽  
2017 ◽  
Vol 6 ◽  
Author(s):  
Ismael Al-Ramahi ◽  
Sai Srinivas Panapakkam Giridharan ◽  
Yu-Chi Chen ◽  
Samarjit Patnaik ◽  
Nathaniel Safren ◽  
...  

The discovery of the causative gene for Huntington’s disease (HD) has promoted numerous efforts to uncover cellular pathways that lower levels of mutant huntingtin protein (mHtt) and potentially forestall the appearance of HD-related neurological defects. Using a cell-based model of pathogenic huntingtin expression, we identified a class of compounds that protect cells through selective inhibition of a lipid kinase, PIP4Kγ. Pharmacological inhibition or knock-down of PIP4Kγ modulates the equilibrium between phosphatidylinositide (PI) species within the cell and increases basal autophagy, reducing the total amount of mHtt protein in human patient fibroblasts and aggregates in neurons. In two Drosophila models of Huntington’s disease, genetic knockdown of PIP4K ameliorated neuronal dysfunction and degeneration as assessed using motor performance and retinal degeneration assays respectively. Together, these results suggest that PIP4Kγ is a druggable target whose inhibition enhances productive autophagy and mHtt proteolysis, revealing a useful pharmacological point of intervention for the treatment of Huntington’s disease, and potentially for other neurodegenerative disorders.


2015 ◽  
Vol 125 (5) ◽  
pp. 1979-1986 ◽  
Author(s):  
Edward J. Wild ◽  
Roberto Boggio ◽  
Douglas Langbehn ◽  
Nicola Robertson ◽  
Salman Haider ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document